Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress
Go back to Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress| VERASTEM SHS (NASDAQ: VSTM) | Delayed: 9.86 -0.2 (1.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.06 | 52 Week High | $2.43 | |||
| Open | $10.09 | 52 Week Low | $1.05 | |||
| Day High | $10.22 | P/E | N/A | |||
| Day Low | $9.76 | EPS | $-1.79 | |||
| Volume | 754,158 | |||||



